Alternatively, CTGF has a proliferative role in cancers [15] and our study of Ki-67 immunostaining in vivo was consistent with this mechanistic hypothesis that CTGF block inhibits cell proliferation without alteration of vasculature density. The gene discussed is CCN2; the disease is cancer.